PremjiInvest strikes a deal by investing in Koye Pharmaceuticals

Franchise India Bureau November 29 2018 - 2 min read
PremjiInvest strikes a deal by investing in Koye Pharmaceuticals
This investment will help Koye to strengthen its position in the domestic formulation market and pursue newer business avenues.

PremjiInvest, the family office of Wipro Ltd Chairman Azim Premji, has invested in Mumbai-based Koye Pharmaceuticals Pvt Ltd. The financial details of the transaction have not been disclosed.

This investment will help Koye to strengthen its position in the domestic formulation market and pursue newer business avenues. This is PremjiInvest's first investment in a pharmaceuticals company in India.

Founded in 2013 by Ravindra Shenoy and Preetish Toraskar, Koye makes essential drugs for primary speciality care. The company had first raised external capital from multi-stage investor Sequoia Capital in the same year. 

Entrepreneur Magazine

For hassle free instant subscription, just give your number and email id and our customer care agent will get in touch with you

or Click here to Subscribe Online

Subscribe Newsletter
Submit your email address to receive the latest updates on news & host of opportunities